Left Atrial Appendage Closure: A Narrative Review

被引:0
作者
Takashi Nagasaka
Mamoo Nakamura
机构
[1] Cedars-Sinai Medical Center,Smidt Heart Institute
[2] Gunma University Graduate School of Medicine,Department of Cardiovascular Medicine
来源
Cardiology and Therapy | 2023年 / 12卷
关键词
Atrial fibrillation; Thromboembolic events; Transcatheter left atrial appendage closure;
D O I
暂无
中图分类号
学科分类号
摘要
Atrial fibrillation (AF) is the most common cardiac arrhythmia and the cause of thromboembolic events in elderly patients worldwide. AF is associated with a significantly increased risk of morbidity and mortality due to cardiac emboli, primarily from left atrial appendage (LAA) thrombus. Oral anticoagulation therapy is the standard treatment to effectively reduce the risk of thromboembolic events in patients with AF. However, anticoagulation treatment increases bleeding risk. LAA closure (LAAC) has recently been introduced as a feasible mechanical preventive intervention for thromboembolic events while minimizing the risk of bleeding. Transcatheter LAAC devices have evolved in the past decade, and several ongoing trials have demonstrated the improvements of safety and outcomes in newer generation devices. This review summarizes the current perspectives and outcomes regarding LAAC as an alternative to pharmacologic therapy.
引用
收藏
页码:615 / 635
页数:20
相关论文
共 197 条
  • [21] Pisters R(2020)A novel surgical technique of left atrial appendage closure J Card Surg 35 2137-2141
  • [22] Lane DA(2017)Surgical techniques for left atrial appendage exclusion Herzschrittmacherther Elektrophysiol 28 360-365
  • [23] Nieuwlaat R(2011)Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial J Thorac Cardiovasc Surg 142 1009.e1-2091
  • [24] de Vos CB(2021)Left atrial appendage occlusion during cardiac surgery to prevent stroke N Engl J Med 384 2081-1889
  • [25] Crijns HJ(2002)Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience Circulation 105 1887-600
  • [26] Lip GY(2009)Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (percutaneous left atrial appendage transcatheter occlusion) study JACC Cardiovasc Interv 2 594-226
  • [27] Ernst G(2010)PLAATO (percutaneous left atrial appendage transcatheter occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study EuroIntervention 6 220-1495
  • [28] Stöllberger C(2007)Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation J Am Coll Cardiol 49 1490-542
  • [29] Abzieher F(2009)Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 534-12
  • [30] Veinot JP(2014)Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial J Am Coll Cardiol 64 1-2975